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Abstract
Objective—To assess the association between frailty and risk for heart failure (HF) in older
adults.
Background—Frailty is common in the elderly and is associated with adverse health outcomes.
Impact of frailty on HF risk is not known.
Methods—We assessed the association between frailty, using the Health ABC Short Physical
Performance Battery (HABC battery) and the Gill index, and incident HF in 2825 participants
aged 70-79 years.
Results—Mean age of participants was 74±3years; 48% were men and 59% were white. During
a median follow up of 11.4 (7.1-11.7) years, 466 participants developed HF. Compared to non-
frail participants, moderate (hazard ratio HR 1.36, 95%CI 1.08-1.71) and severe frailty (HR 1.88,
95%CI 1.02-3.47) by Gill index was associated with a higher risk for HF. HABC battery score
was linearly associated with HF risk after adjusting for the Health ABC HF Model (HR 1.24,
95%CI 1.13, 1.36 per SD decrease in score), and remained significant when controlled for death as
a competing risk (HR 1.30; 95%CI 1.00-1.55). Results were comparable across age, sex, and race,
and in sub-groups based on diabetes mellitus or cardiovascular disease at baseline. Addition of
HABC battery scores to the Health ABC HF Risk Model improved discrimination (change in C-
index, 0.014; 95%CI 0.018-0.010) and appropriately reclassified 13.4% (NRI 0.073, 95%CI
0.021-0.125; P=0.006) of participants (8.3% who developed HF and 5.1% who did not).
Conclusions—Frailty is independently associated with risk of HF in older adults.
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Frailty; Heart Failure; Elderly
Frailty in older adults is associated with poor physical functioning and outcomes (1,2).
Several studies have suggested an association between frailty and cardiovascular disease
(CVD), with frailty identified in 25-50% of all patients with CVD (3,4). The population
prevalence of frailty in the community is 3-7% among individuals aged 65-75 years, 20-26%
in octogenarians, and a third in nonagenarians(5). Observational studies have shown a strong
association between frailty with incident CVD and mortality in elderly (6-8). The
importance to better understand frailty in context of CVD in elderly was recently
emphasized (9). Heart failure (HF) prevalence is highest in the elderly but there are limited
data on frailty and HF risk. Several mechanistic pathways including inflammation and
metabolic disturbances underlie frailty and may be related to its association with HF;
however limited data exist in this regard (2,10-11).
The study of frailty is complicated by the lack of a consensus definition and the multiplicity
of scales used to define frailty. Physical performance measures have been used to assess
functional status.(12) Gill index categorizes individuals into non-frail, or moderately or
severely frail, based on a combination of chair-stand and walking speed tests(13). Studies
have shown that objective measures of lower extremity function are highly predictive of
subsequent disability and hospitalizations(14-16). The Health Aging and Body Composition
(Health ABC) Short Physical Performance Battery (HABC Battery) evaluates physical
performance via a composite of gait speed, repeated chair stands, and tandem balance
tests(17) and helps to identify individuals with preclinical disability. The objective of this




The Health ABC Study enrolled 3075 well-functioning, community dwelling individuals
aged 70 to 79 years from 1997-1998. Participants were identified from a random sample of
white Medicare beneficiaries and all age eligible black community residents from Pittsburgh
and Memphis. Participants with manifest or missing data on HF at baseline (n=140) were
excluded. Of the 2935 such participants, 2825 (96%) had data for the Gill criteria and
HABC battery, and were included in this analysis.
Study Definitions
Diabetes was defined based on positive history or use of anti-hyperglycemic medication.
Smoking was defined as current, past (≥100 lifetime cigarettes), or never. Physical activity
was ascertained using a standardized questionnaire designed by the Health ABC study.
Kilocalories per week (kcal/week) expended in common exercise (e.g., walking for exercise,
exercise classes, weightlifting) and lifestyle activities (e.g., gardening, housework, yard
work, non-exercise walking) were collected. From the reported duration, intensity, and
estimated metabolic cost (18), a summary variable of kcal/week was calculated for each
activity performed. Left ventricular hypertrophy was defined based on electrocardiogram
using the Minnesota voltage criteria. Hypertension was defined as history of physician
diagnosis accompanied by use of antihypertensive drugs. Coronary heart disease (CHD) was
defined as history of revascularization or electrocardiographic evidence of myocardial
infarction or self-reported history of myocardial infarction or angina accompanied by use of
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anti-anginal medications. Cerebrovascular disease was defined as self-reported history of
stroke, transient ischemic attack, or carotid endarterectomy. Incident CHD events were
defined as hospitalization for myocardial infarction, angina pectoris, or elective coronary
revascularization, either surgical or percutaneous.
Frailty Assessment
The Gill index is based on a composite of chair-stand and walking speed tests (13). Severe
frailty is defined when the subject is unable to stand-up from the chair without the use of the
arms and showed a walking speed lower than 0.6 m/s; moderate frailty was defined as only
one of the two tests being abnormal; and non-frailty if neither were present. Frailty was also
assessed by the Health ABC physical performance battery (17). Briefly, the scale is an
extension of the lower extremity performance tests used in the Epidemiologic Studies of the
Elderly (19) and includes , five repeated chair stands, standing balance (semi-and full-
tandem stands and a single leg stand for 30 second), a 6-m walk to assess usual gait speed,
and a narrow 6-m walk between lines 20 cm apart.. A ratio score from 0 to 1 was created for
each test and the four tests were added to provide a continuous scale from 0 to 4. The
scoring system for the HABC battery was developed to minimize ceiling effects (17). Lower
levels of Health ABC battery score reflect more severe frailty.
Serum Biomarkers
Blood samples were obtained after overnight fasting. Cytokines were measured in duplicate
by ELISA. The detectable limit for interleukin-6 (IL-6) was 0.10 pg/mL and for tumor
necrosis factor-alpha (TNF-α) 0.18 pg/mL. C reactive protein (CRP) was measured in by
ELISA with a sensitivity of 0.08 mg/L. Blind duplicate analyses (n=150) for IL-6, CRP, and
TNF-α showed inter-assay coefficients of variation of 10.3%, 8.0%, and 15.8%,
respectively. Serum resistin was measured using sandwich ELISA; intra- and inter-assay
coefficients of variation for this assay are 4.5% and 7.4%, respectively.14
Study Outcome
All participants were asked to report any hospitalizations. Every 6 months, they were asked
direct questions about interim events. Medical records for hospitalizations were reviewed.
All first admissions confirmed to be related to HF were classified as incident HF. The
Events Committee adjudicated all HF diagnoses. The adjudicators reviewed all pertinent
data, including history, physical examination, chest radiography, and medication use. HF
event was confirmed if in addition to a physician diagnosis, there was (1) documentation of
HF symptoms and signs; (2) supporting findings (e.g. pulmonary edema on X-ray); or (3)
HF treatment, including diuretics, digitalis, ACE inhibitors, or β-blockers were given
(20-21).
Statistical Analysis
Cross-sectional associations of frailty with various risk factors were assessed using linear
regression models adjusted for age and gender. Time-to-event analyses were conducted
using Cox proportional hazard models, stratified by baseline CHD. The proportional hazards
assumption was evaluated by the Schoenfeld residuals. The shape of association with HF
risk was assessed by plotting hazard ratios (HR) calculated within quintile of baseline
HABC battery scores against the mean score within each quintile. Floating variances were
used to calculate 95% confidence intervals (CI) for the HR in each group, including the
reference group, to allow for comparisons across the groups irrespective of the arbitrarily
chosen reference category, i.e. bottom fifth (22). As the association showed an
approximately linear shape, HRs were calculated per SD change in HABC battery,
progressively adjusted for independent clinical predictors of incident HF as identified in the
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Health ABC HF Risk Score (including age, smoking, systolic blood pressure, heart rate,
fasting glucose, left ventricular hypertrophy, serum albumin and creatinine) (23). The HR
was further adjusted for physical activity, inflammatory biomarkers, and time-varying
incident CHD evaluated at 1-year intervals in nested models. These analyses were repeated
in subgroups defined by CVD status at baseline. Finally, analyses were repeated with death
as a competing event, using the competing risks model (proportional sub-hazards model)
proposed by Fine and Gray(24). Appropriate interaction terms were introduced to examine
for differences in HRs across levels of pre-specified characteristics (age, sex, race, history of
diabetes, CHD, and presence of left ventricular hypertrophy). In parallel analyses we also
assessed the risk of incident HF across categories of frailty as defined by the Gill index. The
discriminative properties of the HABC battery score versus Gill index for HF prediction
were compared using Harell’s C-index. To assess the incremental value of frailty in
assessment of HF risk prediction, we calculated C-index for two risk prediction models, one
with the conventional risk predictors using the Health ABC Risk Score as a base model, and
the second with this model plus HABC battery score.
For reclassification, 5-year risk prediction was considered relevant. Individuals whose HF
events occurred after 5 years were categorized as non-cases. The reference risk prediction
model included HABC HF Risk Model, which was then extended to additionally include
HABC battery score as the alternative model. Individuals were classified into <5%, 5-10%,
and >10% 5-year risk categories. Reclassification was summarized using net-
reclassification-improvement [NRI] (25). In addition, we also employed cross-validation
approaches to these analyses (e.g. performing model derivation and validation in separate
subsets of participants) to investigate optimism in estimates of predictive ability. For
multivariable models, missing values of covariates were imputed using multiple imputation
by chained equations as introduced by van Buuren et al(26),(27). Parameter estimates and
confidence intervals (CI) were obtained by combining 5 imputed datasets using the method
described by Barnard and Rubin to account for possible error in missing value analysis(28).
A 2-sided P<0.05 was accepted as statistically significant for all analyses. All analyses were
performed using Stata release 11 (Stata Corp LP, College Station, Texas).
The Health ABC study was supported in part by the Intramural Research Program of the
National Institutes of Health, National Institute on Aging (NIA), and contracts, N 01-
AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant: R01-AG028050, and NINR
grant R01-NR012459. The authors are solely responsible for the design and conduct of this
study, all study analyses, the drafting and editing of the paper and its final contents
RESULTS
Baseline Participant Characteristics
The mean age of participants was 74±3 year; 48% were men and 59% were white. Median
HABC battery score was 2.3 (interquartile range [IQR] 1.9, 2.6). Table 1 presents the
baseline characteristics. Frailty was present in 17.5% (moderate 16.2% and severe 1.3%) of
participants by Gill criteria. Frail participants were older (74±3 vs. 73±3 years, P<0.001),
more frequently women (60.1% vs. 50.4%, P<0.001), and black (53% vs. 38%, P<0.001).
Frailty status by the two indexes was concordant in 1882 (66.7%) participants. Age,
measures of adiposity (body mass index and waist to thigh ratio) and inflammation (tumor
necrosis factor-α, interleukin-6), systolic blood pressure, heart rate, baseline diabetes
mellitus and CVD, and fasting glucose, serum resistin and creatinine levels, all correlated
with HABC battery score, Table 2.
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Frailty and Incident Heart Failure
During a median follow-up of 11.4 (7.1-11.7) years, 466 (15.9%) participants developed HF
(17.7 per 1000 person-years), Figure 1. Compared to non-frail participants, those classified
frail by the Gill index were at higher risk for HF (HR 1.36, 95%CI 1.08-1.71 and HR 1.88,
95%CI 1.02-3.47, for moderate and severe frailty respectively). HABC battery score was
linearly associated with HF risk, Figure 2. In univariate analysis, HABC battery score was
associated with HF risk (HR 1.40, 95%CI 1.28-1.53 per SD decrease in score); this
association persisted after adjustment for HABC HF Risk Score (HR 1.24, 95%CI
1.13-1.36). HR did not vary importantly in analyses that excluded HF events recorded in the
first year of follow-up (data not shown). Progressive adjustments for serum lipids, physical
activity, serum resistin, TNF-α, IL-6, history of arrhythmias and respiratory function (FEV1/
FVC) did not attenuate the association, Table 3. Frailty remained a significant predictor of
HF after controlling for incident CHD as a time varying covariate and death as a competing
event.
The association between HABC battery score and incident HF was similar across subgroups
defined by age, gender, race, prevalent CHD, diabetes mellitus and left ventricular
hypertrophy, Figure 3. HABC battery score had better discrimination than Gill index for HF
prediction (C 0.527 vs. 0.586 for Gill index and SBBP score, respectively), Figure 4. The
Health ABC HF Risk Score yielded a C-index of 0.657 (95%CI 0.646-0.668); addition of
HABC battery score improved the model (change in C index, 0.014; 95%CI 0.018-0.010).
The addition of the HABC battery score to the Health ABC risk predictors appropriately
reclassified 8.3% of participants who developed HF over a 5 year follow-up period, and 5.15
of participants who did not (NRI 0.073, 95%CI 0.021-0.125; P=0.006), Table 4.
Frailty, Incident CHD, and Heart Failure
In participants without CHD at baseline (n=2229), the unadjusted association of frailty using
the HABC battery scores with incident HF risk was similar in those who developed CHD
during follow-up (n=373; HR 1.36, 95%CI 1.16-1.60) and in those who remained free of
CHD (n=1856; HR 1.41, 95%CI 1.21-1.63; P=0.79 for interaction).
DISCUSSION
In this cohort of community-based elderly, frailty was a significant predictor of incident HF.
A unit decrease in HABC battery score, signifying worsening frailty, was associated with
30% (10-55%) increase in HF risk. These findings were consistent in both sexes, and in
blacks and whites, and were independent of clinical risk factors, inflammatory markers,
ankle arm index, incident CHD, and death as a competing event. These results highlight that
frailty raises HF risk independent of other known risk factors.
Poor lower-extremity performance has been previously reported to be predictive of adverse
outcomes (14,29). Simple measures of physical performance such as gait speed and short
walk time capture many aspects of chronic conditions and overall functional status, and may
be combined together as a battery of tests for assessing multi-dimensional syndromes like
frailty. However simple measures like the Gill criteria or the 6 minute walk speeds alone
may be insensitive to capture the early stages of risk typically showing ceiling effects (17).
The HABC battery test based on composite of physical assessments was modeled to address
this limitation while recognizing the multi systemic nature of the frailty syndrome. In our
study, both scales were associated with a higher HF risk.
Frailty has been described as a multidimensional syndrome resulting from the interplay of
genetic, biological, physical, psychological, social and environmental factors (10). Studies
have shown that impairment of inflammatory(10-11) and metabolic pathways(10, 30) may
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be the underlying biological process involved. Consistent with such suggestions, we
observed that frailty was significantly correlated with measures of adiposity, glycemia, and
inflammation. Progressive adjustment for these correlates only mildly attenuated the
association of frailty with HF, suggesting that there are as yet unexplored mediators of the
association between frailty and HF that need to be identified.
Despite of the poor understanding of the biological basis, exercise has been identified as an
important frailty “therapy” shown to improve outcomes and quality of life for these patients
(31). Restoration of physical function through resistance training has shown benefit in frail
elderly (32-34). Physical activity has been seen to have a positive effect on several
modulatory pathways. A decrease in circulating levels of inflammatory markers (35),
production of free radical scavengers (36), and improvement of insulin resistance (37) are all
intrinsic pathways through which physical training helps prevent debility. Recognition of
frailty can alert physicians that the patient may benefit from geriatric care and or an exercise
program.
The Health ABC Study cohort was selected on the basis of absence of disability and
mobility impairment. Thus the distribution of frailty scores may not be representative of the
general population. Echocardiography was not performed at baseline in the Health ABC
Study. Thus, the association of frailty with sub-clinical left ventricular dysfunction could not
be assessed. However, we intended to assess the association between frailty and clinical HF,
and not asymptomatic left ventricular dysfunction. Also, because HF is unlikely to remain
undiagnosed for several years, we contend that the observed association cannot be ascribed
merely to undetected HF at baseline. From prevention perspective, clinically manifest
disease is more relevant, e.g. in coronary disease prevention strategies, participants do not
undergo coronary angiography to rule out sub-clinical coronary disease. Finally
reclassification metrics are sensitive to choice of follow-up interval and clinical risk
categories (32).
In conclusion, we demonstrate a significant association between frailty and risk of incident
HF. in older individuals. These findings were consistent across gender and race, and
persisted after controlling for other HF risk factors. Practical implications of our findings
include screening elderly for frailty with the aim to identify individuals at increased risk for
HF who may benefit from interventions aimed at improving their physical functioning and
quality of life.
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Figure 1. HABC battery score and incident heart failure
Lower baseline HABC battery score was associated with a higher risk for heart failure.
Rates are shown per 1000 person-years.
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Figure 2. HABC battery score and heart failure risk
Hazard ratio and 95% “floating absolute” confidence intervals per quintile Health ABC
battery are shown. The size of the box is proportional to the inverse of the variance of
hazard ratio. Model adjusted for age and gender. Note: The fifth category is the reference
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Figure 3. HABC battery scores and heart failure risk in subgroups
Frailty was associated with higher heart failure risk in multiple subgroups studied. Note: The
model is adjusted for age and gender and stratified for prevalent coronary heart disease.
CVD - Cardiovascular disease; LVH - left ventricular hypertrophy; T2D - type 2 diabetes
mellitus
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Figure 4. Comparison of discrimination of HABC battery scores and Gill index
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Age (years) 73.6 (2.9) 74.0(2.9) 73.2(2.8) <0.001
Female (%) 52.1 64.2 39.8 <0.001
Black race, % 40.6 52.4 28.7 <0.001
Body mass index, kg/m2 27.3(4.7) 28.1(5.2) 26.4(4.0) <0.001
Waist/thigh circumference 1.9(0.2) 1.9(0.2) 1.9(0.2) 0.811
Smoking, % <0.001
Current 45.3 44.7 48.6
Past 10.4 13.4 7.4
Never 44.3 42.0 44.0
Alcohol consumption, % <0.001
Never 49.9 56.9 42.8
<1 drink/week 20.8 19.0 22.7
1–7 drinks/week 21.8 18.6 25.0
>7 drinks/week 7.5 5.5 9.5
Diabetes mellitus, % 14.3 17.2 11.4 <0.001
Hypertension, % 50.0 56.5 43.4 <0.001
Coronary heart disease, % 19.5 20.2 18.9 0.318
Peripheral arterial disease, % 4.7 5.5 3.9 0.041
Left ventricular hypertrophy, % 11.5 13.5 9.5 0.001
Physical activity, kcal/kg/week 83.9(69.2) 76.1(66.9) 91.9(70.5) <0.001
Systolic blood pressure, mm Hg 135.9(20.7) 136.9(21.6) 134.8(19.7) 0.007
Diastolic blood pressure, mm Hg 71.4(11.7) 71.0(12.0) 71.8(11.4) 0.047
Heart rate, beats/min 65.2(11.0) 66.5(11.3)) 91.9(70.5) <0.001
Fasting glucose, mg/dl* 94.0(87.0,105.0) 95.0(87.0,107.0) 93.0(87.0,103.0) 0.001
Albumin, g/dl 4.0(0.3) 4.0(0.3) 71.8(11.4) <0.001
Creatinine, mg/dl* 1.1(0.4) 1.1(0.5) 1.0(0.2) 0.087
Total cholesterol, mg/dl 203.3(38.3) 206.0(39.6) 200.5(36.7) <0.001
Low-density lipoprotein, mg/dl 121.9(34.6) 122.7(36.2) 121.2(33.0) 0.258
High-density lipoprotein, mg/dl 54.3(16.9) 56.3(17.7) 52.2(15.9) <0.001
Triglycerides, mg/dl* 118.0(89.0,163.0)) 117.0(89.0,163.0) 119.0(88.0,163.0) 0.615
Resistin, mg/ml 20.4(10.9) 21.4(11.6) 19.3(10.1) <0.001
TNF alpha, pg/ml* 3.5(1.7) 3.6(1.8) 3.4(1.6) 0.002
Interleukin-6, pg/ml* 2.3(1.9) 2.5(2.0) 2.2(1.8) <0.001
Ankle arm index 1.1(0.2) 1.0(0.2) 1.1(0.2) <0.001
*
HABC battery score, median = 2.3, was used to categorize participants as being frail (<2.3) and non-frail (≥23).
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Table 2
Correlates of HABC battery score
Characteristic r (95% CI)tt P-value
Categorical variable Mean difference (95% CI) compared to ref ‡
Male ref
Female −0.29 (−0.33 to −0.26) <0.001
White race ref
Black race −0.28 (−0.32 to −0.25) <0.001
Smoking
No ref
Current −0.25 (−0.32 to −0.19) <0.001
Past −0.07 (−0.11 to −0.03) <0.001
Alcohol consumption
No ref
<1 drink/week 0.12 (0.07 to 0.17) <0.001
1–7 drinks/week 0.15 (0.11 to 0.20) <0.001
>7 drinks/week 0.11 (0.04 to 0.19) <0.001
No history of Diabetes ref
History of Diabetes −0.22 (−0.27 to −0.17) <0.001
No history of Hypertension ref
History of Hypertension −0.15 (−0.18 to −0.11) <0.001
No history of Coronary heart disease ref
History of Coronary heart disease −0.08 (−0.13 to −0.03) <0.001
No history of Peripheral arterial disease ref
History of Peripheral arterial disease −0.17 (−0.26 to −0.08) <0.001
No history of Left ventricular hypertrophy ref
Left ventricular hypertrophy −0.12 (−0.18 to −0.06) <0.001
Continuous variables Pearson correlation (95% CI) ‡
Age −0.21 (−0.25 to −0.18) <0.001
Body mass index −0.23 (−0.27 to −0.20) <0.001
Waist/thigh circumference ratio −0.08 (−0.11 to −0.04) <0.001
Physical activity, kcal/kg/week 0.15 (0.11 to 0.18) <0.001
Systolic blood pressure −0.05 (−0.09 to −0.01) 0.008
Diastolic blood pressure −0.02 (−0.06 to 0.02) 0.27
Heart rate −0.14 (−0.17 to −0.10) <0.001
Fasting glucose −0.15 (−0.19 to −0.11) <0.001
Albumin 0.07 (0.04 to 0.11) <0.001
Creatinine −0.15 (−0.18 to −0.11) <0.001
Total cholesterol 0.00 (−0.03 to 0.04) 0.83
Low-density lipoprotein 0.01 (−0.03 to 0.05) 0.6
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Characteristic r (95% CI)tt P-value
High-density lipoprotein −0.02 (−0.06 to 0.01) 0.24
Triglycerides 0.02 (−0.02 to 0.06) 0.33
Resistin −0.12(−0.15 to −0.08) <0.001
TNF alpha −0.09 (−0.12 to −0.05) <0.001
Interleukin-6 −0.12 (−0.16 to −0.09) <0.001
Ankle Arm Index 0.14 (0.10 to 0.18) <0.001
Note: lower scores on the HABC battery indicate more severe frailty.
‡Adjusted for age, sex
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Table 3
Heart failure risk per standard deviation decrease in HABC battery score
Factor progressively adjusted for All Participants (n=2,825)
HR (95% CI)
Unadjusted 1.40 (1.28-1.53)
Age and gender 1.36 (1.24-1.48)
plus HABC Score 1.24 (1.13-1.36)
plus high- and low-density lipoprotein, log Triglycerides 1.24 (1.13-1.37)
plus physical activity 1.25 (1.14-1.38)
plus resistin, TNF alpha, interleukin-6 1.23 (1.12-1.36)
plus history of arrhythmias, FEV1/FVC 1.23 (1.12-1.36)
plus time varying incident CHD 1.24 (1.13-1.36)
FEV1/FVC. Ratio of Forced expiratory volume at 1 second to Forced Vital Capacity.
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Table 4
Risk discrimination and reclassification with HABC battery score added to HABC Heart
Failure Risk Model
Discrimination
C-index (95% CI): HABC score 0.657(0.646,0.668)
C-index (95% CI): HABC score plus HABC battery 0.671(0.661,0.682)
C-index change (95% CI) 0.014(0.018,0.010)
P-value <0.001
Reclassification
Participants who did not develop HF at 5 years
 Appropriately reclassified 166(5.18%)
 Inappropriately reclassified 137(6.28%)
Participants who developed HF at 5 years
 Appropriately reclassified 15(8.25%)
 Inappropriately reclassified 4(2.03%)
Net reclassification index (95% CI) 0.073(0.021,0.125)
P-value 0.006
Integrated discrimination index (95% CI) 0.003(−0.046,0.052)
P-value 0.89
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